Welcome to LookChem.com Sign In|Join Free
  • or
2-(5-chloro-1-methyl-1H-indol-3-yl)ethanamine is a chemical compound characterized by the molecular formula C11H12ClN2. It is an indole derivative, a class of organic compounds that are naturally present in various plants. This specific compound features a chlorine atom and a methyl group attached to the indole ring, along with an ethylamine side chain. Its unique structural features make it a versatile molecule for research and pharmaceutical applications, where it can serve as a precursor or intermediate in the synthesis of other compounds. The specific properties and potential uses of 2-(5-chloro-1-methyl-1H-indol-3-yl)ethanamine are context-dependent and may vary according to the particular application.

682802-84-2

Post Buying Request

682802-84-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

682802-84-2 Usage

Uses

Used in Pharmaceutical Research and Development:
2-(5-chloro-1-methyl-1H-indol-3-yl)ethanamine is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Chemical Research:
In the field of chemical research, 2-(5-chloro-1-methyl-1H-indol-3-yl)ethanamine is utilized as a starting material for the exploration of new chemical reactions and the synthesis of novel organic compounds. Its indole core and functional groups provide a foundation for studying the reactivity and properties of related molecules.
Used in Drug Synthesis:
2-(5-chloro-1-methyl-1H-indol-3-yl)ethanamine is used as a precursor in the production of pharmaceuticals, particularly those targeting specific biological pathways or receptors. Its structural modifications can lead to the development of new drugs with improved efficacy and selectivity.
Used in Biochemical Studies:
2-(5-chloro-1-methyl-1H-indol-3-yl)ethanamine is employed in biochemical studies to investigate its interactions with various biological molecules, such as enzymes, receptors, or other proteins. Understanding these interactions can provide insights into the compound's potential therapeutic effects and mechanisms of action.
Used in Material Science:
2-(5-chloro-1-methyl-1H-indol-3-yl)ethanamine may also find applications in material science, where its unique chemical properties can be harnessed to develop new materials with specific characteristics, such as optical, electronic, or sensing properties.

Check Digit Verification of cas no

The CAS Registry Mumber 682802-84-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,2,8,0 and 2 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 682802-84:
(8*6)+(7*8)+(6*2)+(5*8)+(4*0)+(3*2)+(2*8)+(1*4)=182
182 % 10 = 2
So 682802-84-2 is a valid CAS Registry Number.

682802-84-2Relevant academic research and scientific papers

Diels-Alder Cycloaddition of Azepino[4,5-b]indoles Towards Hydrocarbazole Derivatives and Related Heterocycles

Xie, Fukai,Li, Xiang,Xu, Liangyu,Ma, Jun,Sun, Lei,Zhang, Bo,Lin, Bin,Cheng, Maosheng,Liu, Yongxiang

supporting information, p. 873 - 889 (2022/01/26)

An approach to hydrocarbazoles bearing an all-carbon quaternary center at C4a position was developed via a Br?nsted acid-initiated Diels-Alder cycloaddition/retro-aza-Michael addition cascade process from azepino[4,5-b]indoles and commercially available d

Novel D3 Dopamine Receptor Agonists to Treat Dyskinesia in Parkinson's Disease

-

Paragraph 167, (2014/08/19)

The present invention provides a method of inhibiting, suppressing or preventing levodopa-induced dyskinesia in a patient suffering from Parkinson's Disease, comprising the step of administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of inhibiting, suppressing or preventing Parkinson's Disease in a patient, comprising the step of administering to the patient a pharmaceutical composition comprising at least one compound of the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 682802-84-2